AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Nov 18, 2024
35599_dirs_2024-11-18_b66222fd-5662-4755-8dc9-998103b9ad25.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-11-18
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-18 | Common shares | M | 15816 | $2.45 | Acquired | 127381 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | Stock Options | $2.45 | M | 15816 | Disposed | 2026-07-05 | Options (15816) | Direct |
Footnotes
F1: Shares acquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026
F2: Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20